Konstantinos Soufleris

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study

Brian Bressler, Andrés Yarur, Mark S. Silverberg et al. · Journal of Crohn s and Colitis · 2021 · 147 citations · Full text

Pharmacy, Pharmacotherapy, Gastrointestinal Pharmacotherapy +16

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients

Elena Eliadou, Joana Moleiro, Davide Giuseppe Ribaldone et al. · Journal of Crohn s and Colitis · 2019 · 40 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: Incidence and correlation with disease severity and survival

Themistoklis Vassiliadis, Alexander Mpoumponaris, Sofia Vakalopoulou et al. · Hepatology Research · 2010 · 39 citations

Medicine, Hematology, Pathology +17

Endoscopic Balloon Dilatation of NSAID-Induced Sigmoid Diaphragm-Stricture

Georgia Lazaraki, Grigoris Chatzimavroudis, Ioannis Pilpilidis et al. · Annals of Gastroenterology · 2007 · 33 citations · Full text

Medicine, Pharmacotherapy, Surgery +17